Session Information
2006 Midyear Clinical Meeting
Click here to go to the previous page
Hot Topics in Infectious Diseases
Track:
Sessions
Program Code: 287-L01
Date: Thursday, December 7, 2006
Time: 2:00 PM to 4:00 PM
Location:
210B (CC)
MODERATOR:
Melinda M. Neuhauser, Pharm.D., Clinical Pharmacy Specialist, Infectious Diseases, Department Veterans Affairs, Pharmacy Benefits Management & Strategic Health Group, Hines, IL, Clinical Pharmacy Specialist, Infectious Diseases, Department Veterans Affairs, Pharmacy Benefits Management & Strategic Health Group
SPEAKER(S):
Dr. David Bearden, PharmD, Clinical Associate Professor, Oregon State University
It Really Is ALL Infectious Diseases: Human Papillomavirus, Another Vaccine Preventable Disease
Hypervirulent Clostridium Difficile: An Emerging Pathogen
Thomas P. Lodise, Pharm.D., Assistant Professor, Albany College of Pharmacy, Albany, NY
Community-Acquired Methicillin Resistant Staphylococcus aureus: An Alert to Clinicians
Melinda M. Neuhauser, Pharm.D., Clinical Pharmacy Specialist, Infectious Diseases, Department Veterans Affairs, Pharmacy Benefits Management & Strategic Health Group, Hines, IL, Clinical Pharmacy Specialist, Infectious Diseases, Department Veterans Affairs, Pharmacy Benefits Management & Strategic Health Group
End of the Antibiotic Era: A Case Discussion
Description
Learning Objectives: Describe the mechanism of virulence, detection, and epidemiology of the newly discovered hypervirulent strain of Clostridium difficile and discuss recommendations for the appropriate treatment of patients. Describe recent trends in the epidemiology of community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA). List the seven pathogens that have been identified as "bad bugs, no drugs" by the Antimicrobial Availability Task Force of the Infectious Disease Society of America. Explain the epidemiology of the Human Papillomavirus (HPV) sequelae and describe the clinical effectiveness of the quadrivalent HPV vaccine.